Visualitzant O - Articles científics per títol

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Naderi, Elnaz; Schack, Line Meinertz Hybel; Dorling, Leila; Rattay, Tim; Ramos Albiac, Monica; Aguado-Barrera, Miguel E; Fachal, Laura; Altabas González, Manuel; Gutiérrez-Enríquez, Sara; Molla, Meritxell; Reyes López, Victoria; Giraldo Marin, Alexandra (Oxford University Press, 2023-12)

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Taylor, Matthew H.; Aghajanian, Carol; Mier, James; Cohn, Allen L.; Makker, Vicky; OAKNIN, ANA (American Society of Clinical Oncology, 2020-09-10)

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Le Rhun, Emilie; Weller, Michael; van den Bent, Martin; Brandsma, D.; Furtner, Julia; RUDA', Roberta; Seoane, Joan (Elsevier, 2023-10)

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer

Wirth, Lori J.; Brose, Marcia S; Hoff, Ana; Hu, Mimi; Capdevila Castillon, Jaume; Elisei, Rossella (Future Medicine, 2022-09)

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

Pascual García, Mónica; Bonfill Teixidor, Ester; Planas Rigol, Ester; Rubio-Perez, Carlota; Iurlaro, Raffaella; Arias Piñeiro, Alexandra; Cuartas Maza, Ma Isabel; Sala Hojman, Ada; Escudero Monreal, Laura; Martínez Ricarte, Francisco Ramón; Huber Ruano, Isabel; Nuciforo, Paolo Giovanni; Braña Garcia, Irene; Garralda Cabanas, Elena; Vieito Villar, Maria; Espejo Ruiz, Carmen; Sahuquillo Barris, Joan; Tabernero Caturla, Josep; Seoane Suarez, Joan (Nature Research, 2019-06-11)

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial

Macarulla Mercadé, Teresa; Chen, Li-Tzong; Siveke, Jens T.; Bodoky, György; Li, Chung-Pin; Cunningham, David (Wolters Kluwer Health, 2020-01)

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial

Macarulla Mercadé, Teresa; Blanc, Jean-Frédéric; Wang-Gillam, Andrea; Chen, Li-Tzong; Siveke, Jens T.; Mirakhur, Beloo (Elsevier, 2019-05-01)

Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis

Vidal, Laura; Fabregat Franco, Carles; Castet, Florian; Sierra, Alexandre; Balsells Valls, Joaquin; Pando, Elizabeth; Macarulla, Teresa; Charco, Ramon; Vivancos, Ana; Blanco Cuso, Laia (Elsevier, 2023-08-06)

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy

Motzer, Robert; Schmidinger, Manuela; Eto, Masatoshi; Suárez, Cristina; Figlin, Robert; Liu, Yanfang (Future Medicine, 2023-01)

Liver transplantation in metastatic colorectal cancer: are we ready for it?

Salvà, Francesc; DOPAZO, CRISTINA; López, Daniel; Saoudi Gonzalez, Nadia; Charco, Ramon; Ros, Javier; Baraibar, Iosune; Tabernero, Josep; Elez, Elena (Springer Nature, 2023-05)

LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib

Ruiz Demoulin, Salomé; Trenquier, Eva; Dekkar, Sanaa; Deshayes, Sebastien; Boisguerin, Prisca; Serrano, Cesar (MDPI, 2023-04-12)

Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient

Domingues, I.; Cedres Perez, Susana; Callejo Perez, Ana; Vivancos Prellezo, Ana; Martínez Marti, Alexandre; Felip Font, Enriqueta (Elsevier, 2020-01)

Long-term follow-up of recovered MPN patients with COVID-19

Barbui, Tiziano; Iurlo, Alessandra; Masciulli, Arianna; Carobbio, Alessandra; Ghirardi, Arianna; Rossi, Giuseppe; Fox, Maria Laura (Springer Nature, 2021-06-16)

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

Duell, Johannes; Maddocks, Kami J.; González-Barca, Eva; Liberati, Anna Marina; de Vos, Sven; Abrisqueta Costa, Pablo; Jurczak, Wojciech (Ferrata Storti Foundation, 2021-09)

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

Linares, Jenniffer; Sallent-Aragay, Anna; Badia-Ramentol, Jordi; Recort-Bascuas, Alba; Méndez, Ana; Manero-Rupérez, Noemí; Saoudi Gonzalez, Nadia; Elez, Elena; Tabernero, Josep (Nature Portfolio, 2023-02-10)

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

Harvey-Jones, Elizabeth J.; Raghunandan, Maya; Robbez-Masson, Luisa; Magraner-Pardo, Lorena; Alaguthurai, Thanu; Yablonovitch, Arielle; Balmaña, Judith; Serra, Violeta (Elsevier, 2024-04)

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera

TRIGUERO, ANA; Pedraza, Alexandra; Pérez-Encinas, Manuel; Mata Vázquez, María Isabel; Velez Tenza, Patricia; Fox, Maria Laura (Springer, 2022-10)

LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells

Cebrià Costa, Joan Pau; Gonzalez-Perez, Abel; Serra Bardenys, Gemma; Querol, J; Cosín, M; Verde, Gaetano; Nuciforo, Paolo Giovanni; Rodilla Benito, Verónica; Arribas López, Joaquin Vicente; Peiro Sales, Sandra; Bernadó Morales, Cristina; Pascual Reguant, Laura (Springer Nature, 2020-01-02)

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study

Moreno, Victor; Kristeleit, Rebecca; leary, alexandra; DELORD, Jean-Pierre; OAKNIN, ANA; Castellano, Daniel (Springer, 2023-10)

Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study

Longo-Muñoz, Federico; Castellano, D.; Alexandre, Jerome; Chawla, Sant P.; Fernández, Cristian; Kahatt, Carmen; Sanz Garcia, Enrique (Elsevier, 2022-09)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial

Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy

Liver transplantation in metastatic colorectal cancer: are we ready for it?

LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib

Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient

Long-term follow-up of recovered MPN patients with COVID-19

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera

LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study

Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types ﻿

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer ﻿

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ﻿

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer ﻿

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy ﻿

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial ﻿

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial ﻿

Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis ﻿

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy ﻿

Liver transplantation in metastatic colorectal cancer: are we ready for it? ﻿

LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib ﻿

Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient ﻿

Long-term follow-up of recovered MPN patients with COVID-19 ﻿

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma ﻿

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy ﻿

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer ﻿

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera ﻿

LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells ﻿

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study ﻿

Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial

Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis

LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy

Liver transplantation in metastatic colorectal cancer: are we ready for it?

LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib

Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient

Long-term follow-up of recovered MPN patients with COVID-19

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera

LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study

Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study